about
Hepatotoxicity of targeted therapy for cancer.Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseTargeting epidermal growth factor receptor in the management of lung cancer.Personalized therapy for hepatocellular carcinoma: Where are we now?Dacomitinib for the treatment of advanced or metastatic non-small-cell lung cancer.Piperacillin/tazobactam Induced Myelosuppression.A lady with unresolved loin pain.Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma
P50
Q30250288-2748128E-0D46-435A-A76B-AF029CE46662Q33422744-0BF536CC-283A-4C5F-A847-6B179FAF5B0CQ38190731-DA35B36B-6F5B-46A4-8196-9FBA5957A2C1Q38782012-32BBD054-B400-4E6C-AB38-267B2DBAAE0AQ39198033-33C4BE28-4833-4EDE-9D68-8F296F60842BQ42260223-2914E1BA-FC45-40E4-B864-337C7B16E759Q53433030-733AFDA7-F033-4377-A75C-A9DAC3AB62DBQ82531886-099FBFD6-09BA-4667-B8E2-E676B643FC0A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Kirsty Wai Chung Lee
@en
Kirsty Wai Chung Lee
@nl
type
label
Kirsty Wai Chung Lee
@en
Kirsty Wai Chung Lee
@nl
prefLabel
Kirsty Wai Chung Lee
@en
Kirsty Wai Chung Lee
@nl
P31
P496
0000-0002-6446-6585